Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials

Non-alcoholic fatty liver disease (NAFLD) is a global public health issue, of which the prevalence is about 25% worldwide. The incidence of NAFLD is increasing in patients with obesity, type 2 diabetes (T2DM) and the metabolic syndrome. The crosstalk between gut microbiota and metabolism-related dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chujin, Shi, Mengxia, Wang, Xiuru, Yao, Ying, Zeng, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349203/
https://www.ncbi.nlm.nih.gov/pubmed/37457967
http://dx.doi.org/10.3389/fnut.2023.1155306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349203/
https://www.ncbi.nlm.nih.gov/pubmed/37457967
http://dx.doi.org/10.3389/fnut.2023.1155306

Ejemplares similares